Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adial Pharmaceuticals (ADIL) Accounts Payables (2022 - 2024)

Adial Pharmaceuticals' Accounts Payables history spans 3 years, with the latest figure at $318118.0 for Q3 2024.

  • For Q3 2024, Accounts Payables rose 288.3% year-over-year to $318118.0; the TTM value through Sep 2024 reached $318118.0, up 288.3%, while the annual FY2023 figure was $103325.0, 62.62% down from the prior year.
  • Accounts Payables for Q3 2024 was $318118.0 at Adial Pharmaceuticals, roughly flat from $316726.0 in the prior quarter.
  • Across five years, Accounts Payables topped out at $617778.0 in Q2 2022 and bottomed at $81925.0 in Q3 2023.
  • The 3-year median for Accounts Payables is $278200.0 (2022), against an average of $293352.6.
  • The largest annual shift saw Accounts Payables tumbled 81.92% in 2023 before it soared 288.3% in 2024.
  • A 3-year view of Accounts Payables shows it stood at $276410.0 in 2022, then plummeted by 62.62% to $103325.0 in 2023, then surged by 207.88% to $318118.0 in 2024.
  • Per Business Quant, the three most recent readings for ADIL's Accounts Payables are $318118.0 (Q3 2024), $316726.0 (Q2 2024), and $177468.0 (Q1 2024).